FDA Warns Medical Food Co. Amid Continuing Crackdown

By Jeff Overley (January 21, 2014, 5:43 PM EST) -- The U.S. Food and Drug Administration on Tuesday released a new warning letter accusing California-based NVN Therapeutics of illegally selling a prescription drug under the guise of so-called medical foods, continuing a sudden crackdown on the niche nutritional products.

In the warning letter, regulators took issue with a product called Glucorein PCOS, which is promoted to alleviate a common disorder known as polycystic ovary syndrome.

The product's active ingredients are chlorogenic acid and L-cysteine, but such is irrelevant because "there are no distinctive nutritional requirements ... for individuals with [the syndrome]," according to the warning letter, which was sent on Dec....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!